This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Raymond Troiano, MD; Stuart D. Cook, MD; Peter C. Dolwing, MD
Department of Neurosciences University of Medicine and Dentistry of New Jersey New Jersey Medical School 185 S Orange Ave Newark, NJ 07103-2757

Arch Neurol. 1989;46(4):362.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—In reply to the letter by Davis and Stefoski¹ we agree that the discovery of corticotropin receptors on lymphocytes and the secretion of corticotropinlike substances by lymphocytes is a provocative area for investigation. These observations will be important if it can be shown that the direct effect of corticotropin on lymphocytes causes clinically significant effects on immunoregulation. The syndrome of corticotropin insensitivity has been reported in over 60 patients. These patients have presented with hyperpigmentation, hypoglycemia, low serum cortisol levels, adrenal unresponsiveness to corticotropin stimulation, and high serum corticotropin levels. In a recent case report of a young child, the corticotropin insensitivity syndrome was associated with an absence of high-affinity corticotropin receptors on circulating peripheral mononuclear leukocytes.² The patient did have recurrent infections while hypoglycemic with very low serum cortisol levels. However, while maintained on cortisol replacement therapy, the patient has remained clinically stable for years . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?